Table 3. Hospital outcomes before and after medical education intervention.
| Variables | Before intervention (n = 93) | After intervention (n = 97) | p value |
|---|---|---|---|
| Metformin use (n) | 23 (24.7) | 30 (30.9) | 0.341 |
| NPH insulin use (n) | 31 (33.3) | 50 (51.5) | 0.011 |
| Regular insulin use (n) | 17 (18.3) | 5 (5.2) | 0.005 |
| Sliding-scale insulin use (n) | 2 (2.2) | 0 (0) | 0.147 |
| HbA1C request (n) | 37 (39.5) | 51 (52.6) | 0.077 |
| Correct monitoring in patients with OR (n) | 52 (80) | 66 (82.5) | 0.701 |
| Correct monitoring in patients with NT (n) | 12 (63.2) | 12 (70.6) | 0.637 |
| Antibiotic therapy (n) | 62 (66.7) | 64 (66) | 0.920 |
| DM expert assessment (n) | 10 (10.8) | 10 (10.3) | 0.921 |
| Hospital stay (days) | 15 (9 – 31.5) | 13 (7 – 28) | 0.529 |
| Capillary glycemia in the target | 22.2 (9.1 – 33.3) | 22.2 (12.5 – 40.0) | 0.588 |
| Hyperglycemia | 38.5 (12.9 – 62.5) | 45.5 (20.0 – 67.7) | 0.312 |
| Hypoglycemia | 0 (0 – 1.9)* | 0 (0 – 0)* | 0.026 |
Data presented as mean ± standard deviation, n (%) and median (interquartile range)
*
Data shown as median (p5 to 95).
NPH: neutral protamine Hagedorn; HbA1C: glycated hemoglobin; OR: oral route; NT: nasoenteral tube; DM: diabetes mellitus.